Doctor John Molvin

Differences in clinical profile, treatment and outcomes between heart failure patients treated in cardiology wards and internal medicine wards

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Chronic Heart Failure 4

Access

0

The antimicrobial protein Azurocidin-1 is associated with prevalent diastolic dysfunction and incident congestive heart failure in a Swedish population cohort

Event: ESC CONGRESS 2019

Topic: Biomarkers

Session: Chronic Heart Failure - Clinical mixed

Access

0

The clinical use of bioactive adrenomedullin and proenkephalin A in detecting congestion, renal dysfunction and clinical outcomes in two independent acute heart failure cohorts

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Moderated Poster Session - Acute heart failure

Access

0

Galectin 4 bridging the gap in cardiometabolic disease predicting diabetes, coronary events and mortality in a Swedish population cohort

Event: ESC Congress 2018

Topic: Biomarkers

Session: The basic science of diabetes and the metabolic syndrome

Access

0

Cardiovascular biomarkers predict post-discharge rehospitalization risk and mortality among swedish heart failure patients

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Access

0

A diabetes associated HNF1B polymorphism increases risk of prevalent diastolic dysfunction in two independent Swedish population cohorts

Event: ESC CONGRESS 2016

Topic: Diastolic dysfunction

Session: Diastolic function

Access

0

Diabetes associated DNA variants relation with prevalent left ventricular hypertrophy and diastolic dysfunction

Event: HEART FAILURE 2016

Topic: Molecular biology / genetics

Session: Basic Science: Molecular biology / Genetics

Access

0

Doctor John Molvin

Contributor content

Differences in clinical profile, treatment and outcomes between heart failure patients treated in cardiology wards and internal medicine wards

The antimicrobial protein Azurocidin-1 is associated with prevalent diastolic dysfunction and incident congestive heart failure in a Swedish population cohort

The clinical use of bioactive adrenomedullin and proenkephalin A in detecting congestion, renal dysfunction and clinical outcomes in two independent acute heart failure cohorts

Galectin 4 bridging the gap in cardiometabolic disease predicting diabetes, coronary events and mortality in a Swedish population cohort

Cardiovascular biomarkers predict post-discharge rehospitalization risk and mortality among swedish heart failure patients

A diabetes associated HNF1B polymorphism increases risk of prevalent diastolic dysfunction in two independent Swedish population cohorts

Diabetes associated DNA variants relation with prevalent left ventricular hypertrophy and diastolic dysfunction

This platform is supported by